205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.46%
Some net income increase while MRVL is negative at -71.45%. John Neff would see a short-term edge over the struggling competitor.
0.45%
Some D&A expansion while MRVL is negative at -26.00%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-116.67%
Negative yoy deferred tax while MRVL stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.30%
SBC growth of 9.30% while MRVL is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-1385.71%
Negative yoy working capital usage while MRVL is 132.79%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-260.90%
AR is negative yoy while MRVL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
13.95%
Inventory shrinking or stable vs. MRVL's 241.87%, indicating lean supply management. David Dodd would confirm no demand shortfall.
No Data
No Data available this quarter, please select a different quarter.
317.86%
Growth well above MRVL's 129.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-100.00%
Both negative yoy, with MRVL at -103.33%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-29.07%
Negative yoy CFO while MRVL is 32.42%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
49.77%
CapEx growth well above MRVL's 22.86%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
28.02%
Purchases growth of 28.02% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
24.03%
Liquidation growth of 24.03% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
92.17%
Investing outflow well above MRVL's 41.59%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both yoy lines negative, with MRVL at -96.84%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-43.18%
We cut yoy buybacks while MRVL is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.